The Chagas (T. cruzi) qPCR test is a crucial tool for the accurate detection of Trypanosoma cruzi infection, a disease that often goes undiagnosed due to its asymptomatic nature in the early stages. With an estimated 300,000 people infected in the United States, this test is vital for identifying individuals at risk—particularly transplant recipients, who may face potential transmission from donor organs, or immunocompromised patients, who are at risk for reactivation of a prior infection.

At Eurofins Viracor, we offer a well-established preanalytical process that significantly reduces testing delays and minimizes instances of testing not performed (TNP). Our Chagas (T. cruzi) qPCR test is a sensitive, quantitative PCR assay with rapid turnaround times, delivering results within a day.